Merck Net Profit Margin 2010-2024 | MKKGY
Current and historical net profit margin for Merck (MKKGY) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Merck net profit margin for the three months ending June 30, 2024 was .
| Merck Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-06-30 |
$22.58B |
$2.84B |
12.58% |
| 2024-03-31 |
$22.60B |
$2.96B |
13.08% |
| 2023-12-31 |
$22.72B |
$3.06B |
13.45% |
| 2023-09-30 |
$22.91B |
$3.09B |
13.49% |
| 2023-06-30 |
$23.13B |
$3.22B |
13.91% |
| 2023-03-31 |
$23.27B |
$3.37B |
14.49% |
| 2022-12-31 |
$23.42B |
$3.51B |
14.96% |
| 2022-09-30 |
$23.58B |
$3.76B |
15.94% |
| 2022-06-30 |
$23.60B |
$3.73B |
15.79% |
| 2022-03-31 |
$23.54B |
$3.70B |
15.73% |
| 2021-12-31 |
$23.29B |
$3.62B |
15.52% |
| 2021-09-30 |
$22.79B |
$3.20B |
14.05% |
| 2021-06-30 |
$22.12B |
$3.25B |
14.67% |
| 2021-03-31 |
$20.79B |
$2.67B |
12.83% |
| 2020-12-31 |
$20.03B |
$2.27B |
11.33% |
| 2020-09-30 |
$19.42B |
$2.12B |
10.90% |
| 2020-06-30 |
$18.73B |
$1.56B |
8.31% |
| 2020-03-31 |
$18.66B |
$1.77B |
9.47% |
| 2019-12-31 |
$18.09B |
$1.48B |
8.17% |
| 2019-09-30 |
$17.42B |
$4.00B |
22.96% |
| 2019-06-30 |
$17.27B |
$4.02B |
23.24% |
| 2019-03-31 |
$17.24B |
$3.78B |
21.93% |
| 2018-12-31 |
$17.52B |
$3.99B |
22.74% |
| 2018-09-30 |
$17.87B |
$2.27B |
12.71% |
| 2018-06-30 |
$17.90B |
$2.63B |
14.72% |
| 2018-03-31 |
$17.75B |
$2.80B |
15.79% |
| 2017-12-31 |
$17.32B |
$2.94B |
16.96% |
| 2017-09-30 |
$16.90B |
$2.06B |
12.21% |
| 2017-06-30 |
$16.68B |
$1.82B |
10.89% |
| 2017-03-31 |
$16.70B |
$1.71B |
10.21% |
| 2016-12-31 |
$16.63B |
$1.80B |
10.84% |
| 2016-09-30 |
$16.29B |
$1.65B |
10.14% |
| 2016-06-30 |
$15.63B |
$1.55B |
9.91% |
| 2016-03-31 |
$14.89B |
$1.58B |
10.59% |
| 2015-12-31 |
$14.31B |
$1.25B |
8.71% |
| 2015-09-30 |
$13.91B |
$1.42B |
10.21% |
| 2015-06-30 |
$14.32B |
$1.35B |
9.39% |
| 2015-03-31 |
$14.59B |
$1.37B |
9.39% |
| 2014-12-31 |
$14.78B |
$1.50B |
10.12% |
| 2014-09-30 |
$15.11B |
$1.56B |
10.35% |
| 2014-06-30 |
$14.86B |
$1.68B |
11.33% |
| 2014-03-31 |
$14.80B |
$1.70B |
11.47% |
| 2013-12-31 |
$14.72B |
$1.60B |
10.84% |
| 2013-09-30 |
$14.64B |
$1.56B |
10.68% |
| 2013-06-30 |
$14.55B |
$1.35B |
9.25% |
| 2013-03-31 |
$14.30B |
$0.85B |
5.94% |
| 2012-12-31 |
$14.00B |
$0.73B |
5.19% |
| 2012-09-30 |
$13.66B |
$0.55B |
4.06% |
| 2012-06-30 |
$13.69B |
$0.64B |
4.70% |
| 2012-03-31 |
$13.85B |
$0.60B |
4.31% |
| 2011-12-31 |
$14.08B |
$0.84B |
5.97% |
| 2011-09-30 |
$14.47B |
$0.75B |
5.20% |
| 2011-06-30 |
$14.03B |
$0.70B |
5.01% |
| 2011-03-31 |
$13.05B |
$1.05B |
8.05% |
| 2010-12-31 |
$12.34B |
$0.84B |
6.81% |
| 2010-09-30 |
$11.61B |
$0.83B |
7.17% |
| 2010-06-30 |
$11.25B |
$0.77B |
6.82% |
| 2010-03-31 |
$11.14B |
$0.69B |
6.20% |
| 2009-12-31 |
$10.81B |
$0.51B |
4.73% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
